why do we keep making excuses, page-6

I don't consider this to be an excuse, its just my perspective.

As recently as the AGM, Lucy Turnbull confirmed the company's committment to proceed with the Nasdaq listing.
Whilst there was some delay earlier in the year with the regulatory requirements in relation to annual financial accounts having to be brought into line, we are not aware of any other impediments.

My own conclusion (and I stress it is only speculation on my part) is that it is PRR (based on advice from their US advisers) that have decided that the timing is not suitable to list at the moment.

Firstly, the general market turmoil sees speculative stocks being punished, regardless of their prospects.

Secondly, the market has flogged Dendreon for its initial commercial implementation failings and is waiting to see if it can successfully rectify them. Like it or not, PRR would be drawn in direct comparison to DNDN.

An unsuccessful listing in the US could potentially do serious damage to the corporate reputation of PRR, so better to wait until the climate is right. Meanwhile, the significant compliance costs of maintaining the listing are being saved.

As to why (if the above is indeed the case) they don't just come out and say so? Well, it's been discussed ad nauseum that MR has stated they were strongly advised to say as little as possible about the listing, other than it is still on the agenda.

Frankly, I think all this is just a sideshow. The main game is about progressing the clinical trial agenda and developing the commercial opportunities. Thus far, they have been pretty much hitting the milestones, and to me that is far more important.

But then I admit, my investment horizon is longer term and the interim trading range is of little concern.